Researchers at New York University have devised a mathematical approach to predict the structures of crystals—a critical step in developing many medicines and electronic devices—in a matter of ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Pinterest's Q3 update showed strong fundamentals with 11% user growth and 18% revenue growth, yet the stock fell 16%. Read ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Fourth Quarter Loss per Share Guidance: Expected to range from $0.10 to $0.65. Medifast Inc (NYSE:MED) is actively adapting to the changing weight loss market by developing new programs tailored for ...

Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft ...

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With ...

Wellness company Medifast (NYSE:MED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell ...

Medifast (MED) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $2.12 per share a year ago. These ...

For the current quarter ending in December, Medifast expects its per-share earnings to range from 10 cents to 65 cents. The company said it expects revenue in the range of $100 million to $120 million ...